21,823 Agilent Technologies, Inc. $A Shares Acquired by Ethic Inc.

Ethic Inc. grew its holdings in Agilent Technologies, Inc. (NYSE:A) by 102.7% during the 3rd quarter, Holdings Channel reports. The fund owned 43,082 shares of the medical research company’s stock after purchasing an additional 21,823 shares during the period. Ethic Inc.’s holdings in Agilent Technologies were worth $7,424,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. State Street Corp raised its holdings in shares of Agilent Technologies by 0.7% during the second quarter. State Street Corp now owns 12,854,230 shares of the medical research company’s stock worth $1,710,658,000 after purchasing an additional 89,598 shares during the last quarter. Wellington Management Group LLP lifted its position in Agilent Technologies by 2.7% during the second quarter. Wellington Management Group LLP now owns 7,454,686 shares of the medical research company’s stock valued at $990,206,000 after purchasing an additional 198,253 shares during the period. Deutsche Bank AG boosted its holdings in Agilent Technologies by 17.1% in the second quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock valued at $930,957,000 after purchasing an additional 1,024,516 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in Agilent Technologies by 87.4% in the second quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock valued at $695,227,000 after purchasing an additional 2,440,360 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its position in Agilent Technologies by 9.6% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,108,764 shares of the medical research company’s stock worth $240,336,000 after purchasing an additional 185,223 shares during the period.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a report on Saturday, October 17th. Wells Fargo & Company raised their target price on Agilent Technologies from $160.00 to $180.00 and gave the stock an “overweight” rating in a report on Friday, August 28th. TD Cowen raised their target price on Agilent Technologies from $180.00 to $196.00 and gave the stock a “buy” rating in a report on Tuesday, October 13th. Sanford C. Bernstein boosted their price target on Agilent Technologies from $155.00 to $180.00 and gave the company an “outperform” rating in a report on Thursday, August 27th. Finally, The Goldman Sachs Group boosted their price target on Agilent Technologies from $175.00 to $185.00 and gave the company a “buy” rating in a report on Monday, September 21st. Eighteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $181.45.

Insiders Place Their Bets

In related news, Director Mikael Dolsten sold 634 shares of the company’s stock in a transaction dated Friday, September 4th. The stock was sold at an average price of $151.38, for a total value of $95,974.92. Following the completion of the transaction, the director owned 4,924 shares of the company’s stock, valued at approximately $745,395.12. This represents a 11.41% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Agilent Technologies Stock Up 3.0%

A stock opened at $180.09 on Tuesday. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $182.99. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.56 and a current ratio of 2.05. The firm’s fifty day moving average is $166.45 and its 200 day moving average is $137.40. The firm has a market cap of $50.77 billion, a PE ratio of 29.24, a P/E/G ratio of 2.59 and a beta of 1.24.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, topping analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The business had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. During the same quarter in the prior year, the firm posted $1.37 earnings per share. The company’s revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, research analysts forecast that Agilent Technologies, Inc. will post 6.20 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 28th. Investors of record on Tuesday, October 6th were paid a $0.2550 dividend. This represents a $1.02 annualized dividend and a dividend yield of 0.6%. The ex-dividend date was Tuesday, October 6th. Agilent Technologies’s payout ratio is currently 20.08%.

Agilent Technologies Profile

Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research.

The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.

Agilent became an independent company in 1999 through a spin-off from Hewlett-Packard.